Donor multipotent mesenchymal stromal cells may engraft in pediatric patients given either cord blood or bone marrow transplantation

Experimental Hematology

Volumn 34, Issue 7, 2006, Pages 934-942

  Pozzi, Sara ^a   Lisini, Daniela ^b   Podestà, Marina ^a   Bernardo, Maria Ester ^b   Sessarego, Nadia ^a   Piaggio, Giovanna ^a   Cometa, Angela ^b   Giorgiani, Giovanna ^b   Mina, Tommaso ^b   Buldini, Barbara ^b   Maccario, Rita ^b   Frassoni, Francesco ^a   Locatelli, Franco ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; AMELOGENIN; BETA1 INTEGRIN; CD14 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; HERMES ANTIGEN; MICROSOMAL AMINOPEPTIDASE; VASCULAR CELL ADHESION MOLECULE 1;

ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ASPIRATION; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; CHILD; CHILDHOOD CANCER; CHILDHOOD DISEASE; CHIMERA; CLINICAL ARTICLE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CRYOPRESERVATION; DONOR; ENGRAFTMENT; FEMALE; HUMAN; MALE; MESENCHYMAL STEM CELL; MICROSATELLITE MARKER; MULTIPOTENT STEM CELL; PEDIATRICS; PRIORITY JOURNAL; STROMA CELL;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FETAL BLOOD; HUMANS; INFANT; MESODERM; STROMAL CELLS;

EID: 33745215431     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2006.03.007     Document Type: Article

References (42)

1. Caplan A.I. The mesengenic process. Clin Plast Surg 21 (1994) 429-435
2. Prockop D.J. Marrow stromal cells as stem cell from nonhematopoietic tissues. Science 276 (1997) 71-74
3. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
4. Bianco P., and Gehron Robey P. Marrow stromal stem cells. J Clin Invest 105 (2000) 1663-1668
5. Bartolomew A., Sturgeon C., Siatskas M., et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30 (2002) 42-48
6. Tse W.T., Pendleton J.D., Beyer W.M., et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75 (2003) 389-397
7. + T-cell subsets expressing regulatory/suppressive phenotype. Haematologica 90 4 (2005) 516-525
8. Deans R.J., and Moseley A.B. Mesenchymal stem cells: biology and potential clinical use. Exp Hermatol 28 (2000) 875-884
9. Barry F.P., and Murphy J.M. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 36 (2004) 568-584
10. Jorgensen C., Gordeladze J., and Noel D. Tissue engineering through autologous mesenchymal stem cells. Curr Opin Biotechnol 15 (2004) 406-410
11. Koc O.N., Gerson S.L., Cooper B.M., et al. Rapid hematopoietic recovery after co-infusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 18 (2000) 307-316
12. Lazarus H.M., Koc O.N., Devine S.M., et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 11 (2005) 389-398
13. Le Blanc K., Rasmusson I., Sundberg B., et al. Treatment of severe graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363 (2004) 1439-1441
14. Frassoni F., Labopin M., Bacigalupo A., et al. Expanded mesenchymal stem cells (MSC), co-infused with HLA-identical hematopoietic stem cell transplant, reduce acute and chronic graft versus host disease: a matched pair analysis. [abstract]. Bone Marrow Transplant 29 Suppl 2 (2002) 75
15. Horwitz E.M., Prockop D.J., Fitzpatrick L.A., et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5 (1999) 309-313
16. Horwitz E.M., Gordon P.L., Koo W.K.K., et al. Isolated allogeneic bone marrow derived mesenchymal stem cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci U S A 99 (2002) 8932-8937
17. Le Blanc K., Gotherstrom C., Ringden O., et al. Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 79 (2005) 1607-1614
18. Koc O.N., Day J., Nieder M., Gerson S.L., Lazarus H.M., and Krivit W. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy and Hurler syndrome. Bone Marrow Transplant 30 (2002) 215-222
19. Almeida-Porada G., Flake A.W., Glimp H.A., and Zanjani E.D. Cotransplantation of stroma results in enhancement of engraftment and early expression of donor hematopoietic stem cells in utero. Exp Hematol 27 (1999) 1569-1575
20. Devine S.M., Cobbs C., Jenning M., et al. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into non-human primates. Blood 101 (2003) 2999-3001
21. Simmons P.J., Przepiorka D., Thomas E.D., and Torok-Storb B. Host origin of marrow stromal cells following allogeneic bone marrow transplantation. Nature 328 6129 (1987) 429-432
22. Devine S.M., and Hoffman R. Role of mesenchymal stem cells in hematopoietic stem cell transplantation. Curr Opinion Hematol 7 (2000) 358-363
23. Cilloni D., Carlo-Stella C., Falzetti F., et al. Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation. Blood 96 (2000) 3637-3643
24. Koc O.N., Peters C., Aubourg P., et al. Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases. Exp Hematol 27 (1999) 1675-1681
25. Stute N., Fehse B., Schroder J., et al. Human mesenchymal stem cells are not of donor origin in patients with severe aplastic anemia who underwent sex-mismatched allogeneic bone marrow transplant. J Hematother Stem Cell Res 11 (2002) 977-984
26. Dickhut A., Schwerdtfeger R., Kuklick L., et al. Mesenchymal stem cells obtained after bone marrow transplantation or peripheral blood stem cell transplantation originate from host tissue. Ann Hematol 84 (2005) 722-727
27. Horwitz E.M., Prockop D.J., Gordon P.L., et al. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 97 (2001) 1227-1231
28. Erices A., Conget P., and Minguell J.J. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109 (2000) 235-242
29. Bieback K., Kern S., Kluter H., and Eichler H. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 22 (2004) 625-634
30. Wexler S.A., Donaldson C., Dennung-Kendall P., et al. Adult bone marrow is a rich source of human mesenchymal stem cells but umbilical cord and mobilized adult blood are not. Br J Haematol 12 (2003) 368-374
31. Kang T.J., Yeom J.E., Lee H.J., et al. Growth kinetics of human mesenchymal stem cells from bone marrow and umbilical cord blood. Acta Haematol 112 (2004) 230-233
32. Kogler G., Sensken S., Airey J.A., et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 200 (2004) 123-135
33. Lee O.K., Kuo T.K., Chen W.-M., et al. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103 (2004) 1669-1675
34. Friedenstein A.J., Deriglazova U.F., Kulagina N.N., et al. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 2 (1974) 83-92
35. Castro-Malaspina H., Gay R.E., Resnick G., et al. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 56 (1980) 289-301
36. Pugatsch T., Oppenheim A., and Slavin S. Improved single-step PCR assay for sex identification post-allogeneic sex-mismatched BMT. Bone Marrow Transplant 17 (1996) 273-275
37. Allen R.C., Graves G., and Budowle B. Polymerase chain reaction amplification products separated on rehydratable polyacrylamide gels and stained with silver. Biotechniques 7 (1989) 736-744
38. Awaya N., Rupert K., Bryant E., and Torok-Storb B. Failure of adult marrow-derived stem cells to generate marrow stroma after successful hematopoietic stem cell transplantation. Exp Hematol 30 (2002) 937-942
39. Rieger K., Marinets O., Fietz T., et al. Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cell or bone marrow transplantation. Exp Hematol 33 (2005) 605-611
40. Ferrara J.L., and Yanik G. Acute graft versus host disease: pathophysiology, risk factors, and prevention strategies. Clin Adv Hematol Oncol 3 (2005) 415-419
41. Minjun Y., Xiao Z., Shen L., and Li L. Mid-trimester fetal blood-derived adherent cells share characteristics similar to mesenchymal stem cells but full-term umbilical cord blood does not. Br J Haematol 124 (2003) 666-675
42. O'Flaherty E., Sparrow R., and Szer J. Bone marrow stromal function from patients after bone marrow transplantation. Bone Marrow Transplant 15 (1995) 207-212